ABPRO Holdings Inc
ABP4.770USD
-0.030-0.63%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
12.75MMarket Cap
LossP/E TTM
More Details of ABPRO Holdings Inc Company
Abpro Holdings, Inc. is a biotechnology company. The Company is advancing a pipeline of next generation antibody therapies for human epidermal growth factor receptor 2 (HER2)+cancers, non-HER2+ gastric and liver cancer, and wet age-related macular degeneration and diabetic macular edema. These antibodies are developed using the Company’s proprietary DiversImmune platform. Its two lead product candidates, ABP-102 and ABP-201, feature its next generation tetravalent antibody format (TetraBi antibody format), which binds to two different targets with two distinct binding sites per target. ABP-102 is designed to redirect a patient’s immune system to fight cancer by engaging T cells through co-targeting HER2, and CD3, T-cell co-receptor. ABP-201 is designed to block blood vessel formation and normalize damaged vessels through co-targeting VEGF and ANG-2. It plans to develop ABP-201 to treat vascular disease of the eye, focusing on wet age-related macular degeneration (Wet AMD).
ABPRO Holdings Inc Info
Ticker SymbolABP
Company nameABPRO Holdings Inc
IPO dateJan 14, 2022
CEOSuk (Jin Wook)
Number of employees6
Security typeOrdinary Share
Fiscal year-endJan 14
Address6 St Johns Lane, Floor 5
CityNEW YORK
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code10013
Phone12488907200
Websitehttps://abpro.co/
Ticker SymbolABP
IPO dateJan 14, 2022
CEOSuk (Jin Wook)
Company Executives of ABPRO Holdings Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Jin Wook (Miles) Suk
Mr. Jin Wook (Miles) Suk
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
7.07K
--
Mr. Anthony D. Eisenberg
Mr. Anthony D. Eisenberg
Independent Director
Independent Director
--
--
Mr. Ian Mcdonald
Mr. Ian Mcdonald
Independent Director
Independent Director
--
--
Mr. Young Lee Soo
Mr. Young Lee Soo
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Jin Wook (Miles) Suk
Mr. Jin Wook (Miles) Suk
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
7.07K
--
Mr. Anthony D. Eisenberg
Mr. Anthony D. Eisenberg
Independent Director
Independent Director
--
--
Mr. Ian Mcdonald
Mr. Ian Mcdonald
Independent Director
Independent Director
--
--
Mr. Young Lee Soo
Mr. Young Lee Soo
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Wed, Dec 3
Updated: Wed, Dec 3
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Abpro Bio International Inc
20.26%
Chan (Ian)
10.14%
Atlantic Coastal Acquisition Management II LLC
4.27%
Yorkville Advisors Global, LP.
1.05%
The Vanguard Group, Inc.
0.77%
Other
63.50%
Shareholders
Shareholders
Proportion
Abpro Bio International Inc
20.26%
Chan (Ian)
10.14%
Atlantic Coastal Acquisition Management II LLC
4.27%
Yorkville Advisors Global, LP.
1.05%
The Vanguard Group, Inc.
0.77%
Other
63.50%
Shareholder Types
Shareholders
Proportion
Corporation
24.53%
Individual Investor
10.40%
Investment Advisor/Hedge Fund
1.44%
Investment Advisor
0.85%
Hedge Fund
0.25%
Research Firm
0.19%
Venture Capital
0.11%
Private Equity
0.11%
Other
62.13%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
40
79.88K
3.55%
--
2025Q3
43
79.88K
129.79%
+28.42K
2025Q2
39
48.95K
5.62%
-3.75K
2025Q1
91
52.53K
48.24%
-767.24K
2024Q4
91
52.85K
51.27%
+44.31K
2024Q3
92
8.55K
375.06%
-10.77K
2024Q2
98
19.32K
377.23%
--
2024Q1
100
19.32K
386.75%
-1.03M
2023Q4
100
84.90K
289.83%
-23.91K
2023Q3
99
108.81K
295.67%
-6.50K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Abpro Bio International Inc
16.51M
20.59%
--
--
Sep 02, 2025
Chan (Ian)
9.25M
11.54%
--
--
Sep 02, 2025
Atlantic Coastal Acquisition Management II LLC
3.48M
4.34%
--
--
Sep 02, 2025
The Vanguard Group, Inc.
80.56K
0.1%
--
--
Aug 31, 2025
Suk (Jin Wook)
212.16K
0.26%
-500.00K
-70.21%
Sep 02, 2025
Geode Capital Management, L.L.C.
196.49K
0.25%
+110.16K
+127.59%
Jun 30, 2025
Polar Asset Management Partners Inc.
87.50K
0.11%
-360.00K
-80.45%
Jun 30, 2025
AQR Capital Management, LLC
87.50K
0.11%
--
--
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
RiverNorth Enhanced Pre-Merger SPAC ETF
0%
RiverNorth Enhanced Pre-Merger SPAC ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Oct 22, 2025
Merger
30→1
Date
Type
Ratio
Oct 22, 2025
Merger
30→1
FAQs
Who are the top five shareholders of ABPRO Holdings Inc?
The top five shareholders of ABPRO Holdings Inc are:
Abpro Bio International Inc holds 16.51M shares, accounting for 20.59% of the total shares.
Chan (Ian) holds 9.25M shares, accounting for 11.54% of the total shares.
Atlantic Coastal Acquisition Management II LLC holds 3.48M shares, accounting for 4.34% of the total shares.
The Vanguard Group, Inc. holds 80.56K shares, accounting for 0.10% of the total shares.
Suk (Jin Wook) holds 212.16K shares, accounting for 0.26% of the total shares.
Abpro Bio International Inc holds 16.51M shares, accounting for 20.59% of the total shares.
Chan (Ian) holds 9.25M shares, accounting for 11.54% of the total shares.
Atlantic Coastal Acquisition Management II LLC holds 3.48M shares, accounting for 4.34% of the total shares.
The Vanguard Group, Inc. holds 80.56K shares, accounting for 0.10% of the total shares.
Suk (Jin Wook) holds 212.16K shares, accounting for 0.26% of the total shares.
What are the top three shareholder types of ABPRO Holdings Inc?
The top three shareholder types of ABPRO Holdings Inc are:
Abpro Bio International Inc
Chan (Ian)
Atlantic Coastal Acquisition Management II LLC
Abpro Bio International Inc
Chan (Ian)
Atlantic Coastal Acquisition Management II LLC
How many institutions hold shares of ABPRO Holdings Inc (ABP)?
As of 2025Q4, 40 institutions hold shares of ABPRO Holdings Inc, with a combined market value of approximately 79.88K, accounting for 3.55% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -126.25%.
What is the biggest source of revenue for ABPRO Holdings Inc?
In --, the -- business generated the highest revenue for ABPRO Holdings Inc, amounting to -- and accounting for --% of total revenue.
